Compare HAFC & OMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HAFC | OMDA |
|---|---|---|
| Founded | 1982 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Nursing Services |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 758.9M | 874.4M |
| IPO Year | 1996 | 2025 |
| Metric | HAFC | OMDA |
|---|---|---|
| Price | $28.95 | $14.36 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 9 |
| Target Price | ★ $28.50 | $26.44 |
| AVG Volume (30 Days) | 256.9K | ★ 1.2M |
| Earning Date | 01-27-2026 | 11-06-2025 |
| Dividend Yield | ★ 3.74% | N/A |
| EPS Growth | ★ 15.36 | N/A |
| EPS | ★ 2.40 | N/A |
| Revenue | ★ $246,352,000.00 | $232,342,000.00 |
| Revenue This Year | $19.61 | $52.16 |
| Revenue Next Year | $11.05 | $22.43 |
| P/E Ratio | $12.02 | ★ N/A |
| Revenue Growth | 5.84 | ★ 89.23 |
| 52 Week Low | $19.25 | $14.14 |
| 52 Week High | $29.46 | $28.40 |
| Indicator | HAFC | OMDA |
|---|---|---|
| Relative Strength Index (RSI) | 64.32 | N/A |
| Support Level | $28.42 | N/A |
| Resistance Level | $29.46 | N/A |
| Average True Range (ATR) | 0.51 | 0.00 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 67.00 | 0.00 |
Hanmi Financial Corp is a Los Angeles-based bank that caters to Korean-Americans and other multi-ethnic communities across California, Colorado, Georgia, Illinois, New Jersey, New York, Texas, Virginia, and Washington. The bank mainly focuses on small businesses and commercial and real estate loans. It also offers a variety of international finance and trade services and products, including letters of credit, import financing, and export financing. The Bank's revenues are derived from interest and fees on loans, interest, and dividends on the securities portfolio, service charges on deposit accounts, and sales of SBA loans.
Omada Health Inc empowers individuals to make lasting health changes through personalized, virtual care between doctor's visits. The integrated platform of the company supports members with cardiometabolic conditions like prediabetes, diabetes, hypertension, musculoskeletal issues, and behavioral health needs. The company's specialized care tracks also assist members using GLP-1 medications. The Company delivers measurable health outcomes and value for employers, health plans, health systems, and pharmacy benefit managers.